U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C13H11NO3
Molecular Weight 229.2313
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PHENYL AMINOSALICYLATE

SMILES

NC1=CC=C(C(=O)OC2=CC=CC=C2)C(O)=C1

InChI

InChIKey=DNVVZWSVACQWJE-UHFFFAOYSA-N
InChI=1S/C13H11NO3/c14-9-6-7-11(12(15)8-9)13(16)17-10-4-2-1-3-5-10/h1-8,15H,14H2

HIDE SMILES / InChI
Molecular Formula C13H11NO3
Molecular Weight 229.2313
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including: https://pubchem.ncbi.nlm.nih.gov/compound/8609#section=Top

Phenyl Aminosalicylate is the phenyl ester of para-aminosalicylic acid, reported to have less side effects than simple salts of para-aminosalicylic acid. It’s a second-line antituberculosis drug with a high incidence of hypersensitivity reactions and gastrointestinal upset.

Approval Year

1959
143
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Approved
8583
PHENY-PAS-TEBAMIN

Approved Use

Phenyl Aminosalicylate
Doses

Doses

DosePopulationAdverse events​
2.68 g 3 times / day multiple, oral
Studied dose
Dose: 2.68 g, 3 times / day
Route: oral
Route: multiple
Dose: 2.68 g, 3 times / day
Sources:
https://pubmed.ncbi.nlm.nih.gov/14022105
unhealthy
Health Status: unhealthy
Sex: M+F
Sources:
https://pubmed.ncbi.nlm.nih.gov/14022105
Disc. AE: Nausea, Vomiting...
AEs leading to
discontinuation/dose reduction:
Nausea (0.84%)
Vomiting (0.84%)
Gas (1.68%)
Diarrhea (severe, 0.84%)
Gastrointestinal discomfort (1.68%)
Diarrhea (0.84%)
Anorexia (0.84%)
Nausea (severe, 0.84%)
Vomiting (severe, 0.84%)
Sources:
https://pubmed.ncbi.nlm.nih.gov/14022105
AEs

AEs

AESignificanceDosePopulation
Anorexia 0.84%
Disc. AE
2.68 g 3 times / day multiple, oral
Studied dose
Dose: 2.68 g, 3 times / day
Route: oral
Route: multiple
Dose: 2.68 g, 3 times / day
Sources:
https://pubmed.ncbi.nlm.nih.gov/14022105
unhealthy
Health Status: unhealthy
Sex: M+F
Sources:
https://pubmed.ncbi.nlm.nih.gov/14022105
Diarrhea 0.84%
Disc. AE
2.68 g 3 times / day multiple, oral
Studied dose
Dose: 2.68 g, 3 times / day
Route: oral
Route: multiple
Dose: 2.68 g, 3 times / day
Sources:
https://pubmed.ncbi.nlm.nih.gov/14022105
unhealthy
Health Status: unhealthy
Sex: M+F
Sources:
https://pubmed.ncbi.nlm.nih.gov/14022105
Nausea 0.84%
Disc. AE
2.68 g 3 times / day multiple, oral
Studied dose
Dose: 2.68 g, 3 times / day
Route: oral
Route: multiple
Dose: 2.68 g, 3 times / day
Sources:
https://pubmed.ncbi.nlm.nih.gov/14022105
unhealthy
Health Status: unhealthy
Sex: M+F
Sources:
https://pubmed.ncbi.nlm.nih.gov/14022105
Vomiting 0.84%
Disc. AE
2.68 g 3 times / day multiple, oral
Studied dose
Dose: 2.68 g, 3 times / day
Route: oral
Route: multiple
Dose: 2.68 g, 3 times / day
Sources:
https://pubmed.ncbi.nlm.nih.gov/14022105
unhealthy
Health Status: unhealthy
Sex: M+F
Sources:
https://pubmed.ncbi.nlm.nih.gov/14022105
Gas 1.68%
Disc. AE
2.68 g 3 times / day multiple, oral
Studied dose
Dose: 2.68 g, 3 times / day
Route: oral
Route: multiple
Dose: 2.68 g, 3 times / day
Sources:
https://pubmed.ncbi.nlm.nih.gov/14022105
unhealthy
Health Status: unhealthy
Sex: M+F
Sources:
https://pubmed.ncbi.nlm.nih.gov/14022105
Gastrointestinal discomfort 1.68%
Disc. AE
2.68 g 3 times / day multiple, oral
Studied dose
Dose: 2.68 g, 3 times / day
Route: oral
Route: multiple
Dose: 2.68 g, 3 times / day
Sources:
https://pubmed.ncbi.nlm.nih.gov/14022105
unhealthy
Health Status: unhealthy
Sex: M+F
Sources:
https://pubmed.ncbi.nlm.nih.gov/14022105
Diarrhea severe, 0.84%
Disc. AE
2.68 g 3 times / day multiple, oral
Studied dose
Dose: 2.68 g, 3 times / day
Route: oral
Route: multiple
Dose: 2.68 g, 3 times / day
Sources:
https://pubmed.ncbi.nlm.nih.gov/14022105
unhealthy
Health Status: unhealthy
Sex: M+F
Sources:
https://pubmed.ncbi.nlm.nih.gov/14022105
Nausea severe, 0.84%
Disc. AE
2.68 g 3 times / day multiple, oral
Studied dose
Dose: 2.68 g, 3 times / day
Route: oral
Route: multiple
Dose: 2.68 g, 3 times / day
Sources:
https://pubmed.ncbi.nlm.nih.gov/14022105
unhealthy
Health Status: unhealthy
Sex: M+F
Sources:
https://pubmed.ncbi.nlm.nih.gov/14022105
Vomiting severe, 0.84%
Disc. AE
2.68 g 3 times / day multiple, oral
Studied dose
Dose: 2.68 g, 3 times / day
Route: oral
Route: multiple
Dose: 2.68 g, 3 times / day
Sources:
https://pubmed.ncbi.nlm.nih.gov/14022105
unhealthy
Health Status: unhealthy
Sex: M+F
Sources:
https://pubmed.ncbi.nlm.nih.gov/14022105
Sourcing

Sourcing

Vendor/AggregatorIDURL
001 Chemical
DY517934
https://www.001chemical.com/chem/133-11-9
3B Scientific (Wuhan) Corp
3B3-030324
http://www.3bsc.com/index/pro_info.php?id=51588
AA Blocks
AA0011EP
https://www.aablocks.com/goods/Goods/detail?id=AA0011EP
abcr GmbH
AB562876
http://www.abcr.com/shop/en/AB562876
AEchem Scientific Corp., USA
AE1-002086
http://www.aechemsc.com/info_products/AE1-002086.php
AHH Chemical co.,ltd
MT-01908
http://www.ahhchemical.com/product/MT-01908.html
AHH Chemical co.,ltd
MT-21001
http://www.ahhchemical.com/product/MT-21001.html
AK Scientific, Inc. (AKSCI)
I555
http://www.aksci.com/item_detail.php?cat=I555
Alichem
19126280
http://www.alichem.com/en/products/133-11-9.html
Ark Pharma Scientific Limited
H-028086
http://www.arkpharmtech.com/product/34920.html
AvaChem Scientific
2153
http://www.avachem.com/productSearch.asp?2153
BLD Pharm
BD93688
http://www.bldpharm.com/products/133-11-9.html
Boerchem
BC215233
http://www.boerchem.com/?product_36406.html
ChemMol
30107187
http://www.chemmol.com/chemmol/30107187.html
ChemMol
44005109
http://www.chemmol.com/chemmol/44005109.html
ChemMol
49426666
http://www.chemmol.com/chemmol/49426666.html
ChemMol
81411936
http://www.chemmol.com/chemmol/81411936.html
Chemspace
CSSB00000064859
https://chem-space.com/CSSB00000064859
Debye Scientific
DB-005471
http://www.debyesci.com/DB-005471.html
eNovation Chemicals
Y1003913
https://www.enovationchem.com/ProductDetails.asp?ProductID=Y1003913
Finetech
FT-0631771
http://www.finetechnology-ind.com/prod/detail/pub/133-11-9.html
Hairui
HR144107
http://www.hairuichem.com/en/product/133-11-9.html
iChemical
EBD47230
http://www.ichemical.com/chemicals/cas-133-11-9
Lab Network
LN00238642
https://labnetwork.com/frontend-app/p/#!/moleculedetails/LN00238642
mcule
MCULE-2757697866
https://mcule.com/MCULE-2757697866/
Molcore
MC517934
https://www.molcore.com/product/133-11-9
Oakwood
435798
http://www.oakwoodchemical.com/ProductsList.aspx?CategoryID=-2&txtSearch=195705&ExtHyperLink=1
OChem
5724
http://www.ocheminc.com/index.php?act=psearch&pid=133P119
Smolecule
S588618
https://www.smolecule.com/products/s588618
Vitas-M Laboratory
STL477797
http://www.request.vitasmlab.com/index.php?option=com_search_stk&Itemid=22&stk=STL477797&?utm_source=pubchem&utm_medium=p_search_link&utm_campaign=pubchem_search&utm_content=pubchem_slink
Yuhao Chemical
LL0517
http://www.chemyuhao.com/133-11-9.html
Patents

Patents

US6600063
1

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:58:19 GMT 2025
Edited
by admin
on Mon Mar 31 17:58:19 GMT 2025
Record UNII
52936SIP7V
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PHENYL AMINOSALICYLATE
MI   ORANGE BOOK   USAN  
USAN  
Official Name English
FENAMISAL
INN   MART.   WHO-DD  
INN  
Preferred Name English
NSC-40144
Code English
fenamisal [INN]
Common Name English
FENAMISAL [MART.]
Common Name English
PHENYL AMINOSALICYLATE [MI]
Common Name English
PHENYL AMINOSALICYLATE [ORANGE BOOK]
Common Name English
Phenyl 4-aminosalicylate
Systematic Name English
BENZOIC ACID, 4-AMINO-2-HYDROXY-, PHENYL ESTER
Common Name English
PHENY-PAS-TEBAMIN
Brand Name English
Fenamisal [WHO-DD]
Common Name English
PHENYL AMINOSALICYLATE [USAN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C280
Created by admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
Code System Code Type Description
EPA CompTox
DTXSID7021994
Created by admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
PRIMARY
DRUG BANK
DB06807
Created by admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
PRIMARY
EVMPD
SUB07538MIG
Created by admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
PRIMARY
NSC
40144
Created by admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
PRIMARY
DRUG CENTRAL
2143
Created by admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
PRIMARY
ChEMBL
CHEMBL1200868
Created by admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
PRIMARY
CAS
133-11-9
Created by admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
PRIMARY
MESH
C037254
Created by admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
PRIMARY
PUBCHEM
8609
Created by admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
PRIMARY
INN
1844
Created by admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
PRIMARY
ECHA (EC/EINECS)
205-092-8
Created by admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
PRIMARY
SMS_ID
100000081242
Created by admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
PRIMARY
FDA UNII
52936SIP7V
Created by admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
PRIMARY
MERCK INDEX
m8653
Created by admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
PRIMARY Merck Index
NCI_THESAURUS
C66376
Created by admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
PRIMARY
Related Record Type Details
Structure of PHENYL AMINOSALICYLATE
ACTIVE MOIETY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966